undefined undefined
NaN.000
NaN.00%
Stifel analyst Benjamin Burnett maintains Arcellx (NASDAQ:ACLX) with a Buy and raises the price target from $82 to $83.
05-15 18:47
Evercore ISI launched its coverage with a bullish view on a number of biotech stocks on Tuesday, citing a more constructive view on the sector, which is seeing signs of recovery after years of underpe...
05-14 23:24
During the last three months, 14 analysts shared their evaluations of Arcellx (...
05-14 20:01
Arcellx press release (NASDAQ:ACLX): Q1 GAAP EPS of -$0.14. Revenue of $39.3M. More on Arcellx Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset Seeking Alpha’s Quant ...
05-10 19:10
Arcellx shares are trading higher after the company reported better-than-expect...
05-10 04:41
Arcellx (NASDAQ:ACLX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.51) by 72.55 percent. This is a 75.86 percent increase over losses of $(0.58) per share from the same
05-10 04:27
Needham:重申Arcellx(ACLX.US)评级,由买入调整至买入评级, 目标价81.00美元。
04-11 18:21
Arcellx (NASDAQ:ACLX) reported quarterly earnings of $0.42 per share. This is a 155.26 percent increase over losses of $(0.76) per share from the same period last year. The company reported $63.15 million in sales this
03-01 04:28
Arcellx, Inc. (NASDAQ: ACLX) posted financial results for its fourth quarter on Wednesday.
02-29 21:03
生物科技投资者看好小盘股,对中盘股的乐观情绪也逐渐升温,并认为Fusion和Merus最有可能在今年跑赢大盘。
02-05 07:37